Clinical trial
Safety and Tolerability of Yaq-001 in Patients With Cirrhosis ("CARBALIVE-SAFETY")
NCT03202498 is registered in ClinicalTrials.gov with Yaqrit Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Tolerability of Yaq-001 in Patients With Cirrhosis ("CARBALIVE-SAFETY")
- Lead sponsor
- Yaqrit Ltd
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 28, 2019
- Completion date
- March 26, 2020
- Enrollment
- 31 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.